Cambridge Respiratory Innovations (CRI) creates ground-breaking respiratory technologies. In December 2020 it received funding from BGF and Downing Ventures to fast track research and development of its award-winning N-Tidal device to help medical professionals diagnose and monitor respiratory conditions. The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing.
Business funding insights
BGF explains: initial public offerings (IPOs)
We explain what’s meant by an initial public offering (IPO), also known as listing or ‘going public’.
When to pursue debt refinancing and why
You may find that refinancing or renegotiating your business debts can put you in a stronger financial position. Look at…